Advertisement


Vaccines
World  /  Published 17.09.20

Covid: Moderna eyes 70% vaccine efficacy

If Moderna Inc’s Covid-19 vaccine proves to be at least 70 per cent effective, the company plans to seek emergency authorisation for its use in high-risk groups, the company’s chief execut...
By Reuters in Chicago

India  /  Published 16.09.20

Vaccine: Russia trials on

...
By G.S. Mudur in New Delhi

India  /  Published 16.09.20

Vaccine: nod to resume trials

Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country while revoking i...
By Our Bureau, Agencies in

World  /  Published 15.09.20

Vaccine will be ready by November: China

A senior Chinese health official said a coronavirus vaccine could be available to the public in China as early as November, the state news media reported on Tuesday. Dr Wu Guizhen, the chief expert f...
By New York Times News Service in New York

India  /  Published 13.09.20

Minister causes flutter over Covid vaccine pace

...
By G.S. Mudur in New Delhi

Science Tech  /  Published 13.09.20

Crawl to the top

Seven months into the coronavirus crisis, with more than 30 vaccines rapidly advancing through the rigorous stages of clinical trials, surprisingly, several research groups are placing bets on some th...
By Carl Zimmer in

World  /  Published 12.09.20

Vaccine: Astra resumes trials

AstraZeneca has resumed British clinical trials of its Covid-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. Th...
By Reuters in London

India  /  Published 11.09.20

Indian vaccine clears monkey hurdle

A homegrown Indian vaccine candidate has successfully protected rhesus monkeys from the novel coronavirus disease, government and industry scientists have said, describing its immune response and prot...
By G.S. Mudur in New Delhi

India  /  Published 11.09.20

Serum Institute to suspend vaccine trial

The Pune-based Serum Institute of India said on Thursday that it would suspend its clinical trials of the Oxford candidate vaccine against the coronavirus disease, a day after the central drug regulat...
By G.S. Mudur in New Delhi

India  /  Published 09.09.20

Vaccine: Serum to continue

...
By Amit Roy, G.S. Mudur in London, New Delhi


Advertisement

Download our latest App

to get update on the go...

Advertisement

Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.